Biogaia AB
STO:BIOG B

Watchlist Manager
Biogaia AB Logo
Biogaia AB
STO:BIOG B
Watchlist
Price: 106 SEK -0.09% Market Closed
Market Cap: 10.7B SEK
Have any thoughts about
Biogaia AB?
Write Note

Intrinsic Value

The intrinsic value of one BIOG B stock under the Base Case scenario is 106.42 SEK. Compared to the current market price of 106 SEK, Biogaia AB is Fairly Valued.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BIOG B Intrinsic Value
106.42 SEK
Fairly Valued
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Biogaia AB

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BIOG B cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BIOG B?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Biogaia AB

Provide an overview of the primary business activities
of Biogaia AB.

What unique competitive advantages
does Biogaia AB hold over its rivals?

What risks and challenges
does Biogaia AB face in the near future?

Has there been any significant insider trading activity
in Biogaia AB recently?

Summarize the latest earnings call
of Biogaia AB.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Biogaia AB.

Provide P/S
for Biogaia AB.

Provide P/E
for Biogaia AB.

Provide P/OCF
for Biogaia AB.

Provide P/FCFE
for Biogaia AB.

Provide P/B
for Biogaia AB.

Provide EV/S
for Biogaia AB.

Provide EV/GP
for Biogaia AB.

Provide EV/EBITDA
for Biogaia AB.

Provide EV/EBIT
for Biogaia AB.

Provide EV/OCF
for Biogaia AB.

Provide EV/FCFF
for Biogaia AB.

Provide EV/IC
for Biogaia AB.

Show me price targets
for Biogaia AB made by professional analysts.

What are the Revenue projections
for Biogaia AB?

How accurate were the past Revenue estimates
for Biogaia AB?

What are the Net Income projections
for Biogaia AB?

How accurate were the past Net Income estimates
for Biogaia AB?

What are the EPS projections
for Biogaia AB?

How accurate were the past EPS estimates
for Biogaia AB?

What are the EBIT projections
for Biogaia AB?

How accurate were the past EBIT estimates
for Biogaia AB?

Compare the revenue forecasts
for Biogaia AB with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Biogaia AB and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Biogaia AB against its competitors.

Analyze the profit margins
(gross, operating, and net) of Biogaia AB compared to its peers.

Compare the P/E ratios
of Biogaia AB against its peers.

Discuss the investment returns and shareholder value creation
comparing Biogaia AB with its peers.

Analyze the financial leverage
of Biogaia AB compared to its main competitors.

Show all profitability ratios
for Biogaia AB.

Provide ROE
for Biogaia AB.

Provide ROA
for Biogaia AB.

Provide ROIC
for Biogaia AB.

Provide ROCE
for Biogaia AB.

Provide Gross Margin
for Biogaia AB.

Provide Operating Margin
for Biogaia AB.

Provide Net Margin
for Biogaia AB.

Provide FCF Margin
for Biogaia AB.

Show all solvency ratios
for Biogaia AB.

Provide D/E Ratio
for Biogaia AB.

Provide D/A Ratio
for Biogaia AB.

Provide Interest Coverage Ratio
for Biogaia AB.

Provide Altman Z-Score Ratio
for Biogaia AB.

Provide Quick Ratio
for Biogaia AB.

Provide Current Ratio
for Biogaia AB.

Provide Cash Ratio
for Biogaia AB.

What is the historical Revenue growth
over the last 5 years for Biogaia AB?

What is the historical Net Income growth
over the last 5 years for Biogaia AB?

What is the current Free Cash Flow
of Biogaia AB?

Discuss the annual earnings per share (EPS)
trend over the past five years for Biogaia AB.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Biogaia AB

Current Assets 1.5B
Cash & Short-Term Investments 1.1B
Other Current Assets 381.9m
Non-Current Assets 408.4m
Long-Term Investments 28.1m
PP&E 209.9m
Intangibles 161.1m
Other Non-Current Assets 9.4m
Current Liabilities 192.4m
Other Current Liabilities 192.4m
Non-Current Liabilities 92.8m
Other Non-Current Liabilities 92.8m
Efficiency

Earnings Waterfall
Biogaia AB

Revenue
1.4B SEK
Cost of Revenue
-358.1m SEK
Gross Profit
997.6m SEK
Operating Expenses
-597.1m SEK
Operating Income
400.5m SEK
Other Expenses
-63.7m SEK
Net Income
336.8m SEK

Free Cash Flow Analysis
Biogaia AB

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BIOG B Profitability Score
Profitability Due Diligence

Biogaia AB's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Free Cash Flow
Positive Gross Profit
Positive Operating Income
74/100
Profitability
Score

Biogaia AB's profitability score is 74/100. The higher the profitability score, the more profitable the company is.

BIOG B Solvency Score
Solvency Due Diligence

Biogaia AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Biogaia AB's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BIOG B Price Targets Summary
Biogaia AB

There are no price targets for BIOG B.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BIOG B?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for BIOG B is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Ownership

BIOG B Insider Trading
Buy and sell transactions by insiders

Cumulative Transactions Amount
Period Sold Bought Net
3 Months
6 Months
9 Months
12 Months
Why is insider trading important?

Profile

Biogaia AB Logo
Biogaia AB

Country

Sweden

Industry

Biotechnology

Market Cap

10.7B SEK

Dividend Yield

1.79%

Description

BioGaia AB engages in the development, marketing, and sale of probiotic products. The company is headquartered in Stockholm, Stockholm. The firm develops, markets and sells probiotic products with documented health benefits. The products are primarily based on different strains of the lactic acid bacterium Limosilactobacillus reuteri. The Company’s activities are divided into three segments: The Paediatrics segment drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products; The Adult Health segment (gut health tablets, oral health lozenges and cultures as an ingredient in a licensee’s dairy products) and the Other (royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc.). The firm operates worldwide.

Contact

STOCKHOLM
Stockholm
Kungsbroplan 3
+46855529300.0
sv.biogaia.com

IPO

1998-01-01

Employees

159

Officers

Founder & Chairman
Mr. Peter Rothschild M.Sc. Econ., MBA
CEO & President
Ms. Theresa P. Agnew
Executive VP & CFO
Mr. Alexander Kotsinas M.Sc. (Eng.).
Chief Operating Officer
Ludvig Milesson
Chief Scientific Officer and VP of Research & Development
Mr. Gianfranco Grompone
Chief Legal Officer
Ms. Caroline Mofors
Show More
Vice President of Marketing
Ms. Linda Hagglund
Chief HR Officer
Ms. Angelika Kjelldorff
VP & Chief Commercial Officer
Sebastian Heimfors
Sustainability Manager
Jonathan Gromark
Show Less

See Also

Discover More
What is the Intrinsic Value of one BIOG B stock?

The intrinsic value of one BIOG B stock under the Base Case scenario is 106.42 SEK.

Is BIOG B stock undervalued or overvalued?

Compared to the current market price of 106 SEK, Biogaia AB is Fairly Valued.

Back to Top